Archives

by in
Entry Author Date Location
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Sonexa Therapeutics Receives $1,999,995 New Financing 08/03/12 San Diego
SD Life Sciences Roundup: Illumina, Sophiris Bio, & New Funding Deals 04/05/12 San Diego
Sonexa Therapeutics Garners $1,224,992 New Financing 04/04/12 San Diego
Scale Venture Partners Gives Up On Healthcare & Life Sciences Investing 11/08/11 San Francisco
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News 10/20/11 San Diego
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan 10/18/11 San Diego
Sonexa Therapeutics Receives $999,994 New Funding Round 10/18/11 San Diego
Cypress Bio Gets Buyout Offer, Trius Prepares for IPO, Arena Gains Following Vivus Setback, & More San Diego Life Sciences News 07/22/10 San Diego
Venture Funding Drops Sharply in San Diego; Life Sciences Deals Predominate in Our Top 10 List 07/19/10 San Diego
Page 1 of 1

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.